Morgan Hardy, MD, MPH

Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut

  • 3Articles
  • 9.7KReads
  • 2020–2026Active
  • 5Collaborators
  • 4Citations

About

Morgan Hardy, MD, MPH, is affiliated with the Department of Psychiatry at Yale School of Medicine in New Haven, Connecticut. Hardy has published research on clinical topics including bipolar disorder, major depressive disorder, and psychotherapy. Their work includes studies on antidepressant use in ketamine and esketamine treatment, the application of hypnotic suggestion in ketamine-assisted psychotherapy, and a case report involving serotonin syndrome with multiple medications. Hardy has collaborated frequently with Erin Curran, Gopakumar Panikkar, Rachel Katz, Samuel T. Wilkinson, and Taeho Greg Rhee.

Publications

JCP
SSRI, SNRI, or Other Antidepressant Use Not Associated With Differential Outcomes in Ketamine or Esketamine Treatment
Brief Report

SSRI, SNRI, or Other Antidepressant Use Not Associated With Differential Outcomes in Ketamine or Esketamine Treatment

April 27, 2026

No group differences were seen between concurrent oral antidepressant class and clinical outcomes in patients treated with IV ketamine or IN esketamine.
, , , et al
PCC
Hypnotic Suggestion in Ketamine-Assisted Psychotherapy
Case Report

Hypnotic Suggestion in Ketamine-Assisted Psychotherapy

February 6, 2025

Ketamine combined with an indirect, hypnotic-like suggestion at a key moment prompted important insights and behavior changes that contributed to a patient’s recovery.
PCC
Case Report

A Challenging Case of Serotonin Syndrome

March 5, 2020

Serotonin syndrome can be challenging to recognize. Read this report of serotonin syndrome resulting from use of dextromethorphan-based cough medicine in addition to multiple antidepressant and pain medications.
,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe